Annual Current Liabilities
$87.70 M
-$3.74 M-4.09%
31 December 2023
Summary:
Vanda Pharmaceuticals annual total current liabilities is currently $87.70 million, with the most recent change of -$3.74 million (-4.09%) on 31 December 2023. During the last 3 years, it has risen by +$21.76 million (+33.00%). VNDA annual current liabilities is now -64.84% below its all-time high of $249.45 million, reached on 01 December 2003.VNDA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$89.09 M
-$4.70 M-5.01%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly total current liabilities is currently $89.09 million, with the most recent change of -$4.70 million (-5.01%) on 30 September 2024. Over the past year, it has increased by +$4.25 million (+5.01%). VNDA quarterly current liabilities is now -5.02% below its all-time high of $93.79 million, reached on 31 March 2023.VNDA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.1% | +5.0% |
| 3 y3 years | +33.0% | +23.7% |
| 5 y5 years | +65.4% | +48.5% |
VNDA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.1% | +33.0% | -5.0% | +23.7% |
| 5 y | 5 years | -4.1% | +65.4% | -5.0% | +50.4% |
| alltime | all time | -64.8% | +5304.1% | -5.0% | +2512.0% |
Vanda Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $89.09 M(-5.0%) |
| June 2024 | - | $93.79 M(+0.5%) |
| Mar 2024 | - | $93.34 M(+6.4%) |
| Dec 2023 | $87.70 M(-4.1%) | $87.70 M(+3.4%) |
| Sept 2023 | - | $84.84 M(-2.9%) |
| June 2023 | - | $87.40 M(-6.8%) |
| Mar 2023 | - | $93.79 M(+2.6%) |
| Dec 2022 | $91.44 M(+22.9%) | $91.44 M(-1.3%) |
| Sept 2022 | - | $92.62 M(+4.8%) |
| June 2022 | - | $88.40 M(-2.6%) |
| Mar 2022 | - | $90.74 M(+21.9%) |
| Dec 2021 | $74.42 M(+12.9%) | $74.42 M(+3.4%) |
| Sept 2021 | - | $72.00 M(+0.0%) |
| June 2021 | - | $71.99 M(+16.5%) |
| Mar 2021 | - | $61.78 M(-6.3%) |
| Dec 2020 | $65.94 M(+10.8%) | $65.94 M(+7.5%) |
| Sept 2020 | - | $61.36 M(-0.4%) |
| June 2020 | - | $61.59 M(+4.0%) |
| Mar 2020 | - | $59.22 M(-0.5%) |
| Dec 2019 | $59.51 M(+12.2%) | $59.51 M(-0.8%) |
| Sept 2019 | - | $60.00 M(-4.1%) |
| June 2019 | - | $62.58 M(+5.6%) |
| Mar 2019 | - | $59.27 M(+11.8%) |
| Dec 2018 | $53.02 M(-24.7%) | $53.02 M(+14.6%) |
| Sept 2018 | - | $46.24 M(-1.4%) |
| June 2018 | - | $46.88 M(-34.8%) |
| Mar 2018 | - | $71.95 M(+2.3%) |
| Dec 2017 | $70.36 M(+39.8%) | $70.36 M(-1.6%) |
| Sept 2017 | - | $71.54 M(-5.2%) |
| June 2017 | - | $75.44 M(+3.4%) |
| Mar 2017 | - | $72.97 M(+45.0%) |
| Dec 2016 | $50.32 M(-1.9%) | $50.32 M(-0.7%) |
| Sept 2016 | - | $50.68 M(-2.1%) |
| June 2016 | - | $51.76 M(-6.0%) |
| Mar 2016 | - | $55.04 M(+7.3%) |
| Dec 2015 | $51.32 M(+559.1%) | $51.32 M(+11.8%) |
| Sept 2015 | - | $45.89 M(+1.5%) |
| June 2015 | - | $45.19 M(+42.2%) |
| Mar 2015 | - | $31.79 M(+308.3%) |
| Dec 2014 | $7.79 M(-76.3%) | $7.79 M(-80.0%) |
| Sept 2014 | - | $38.84 M(+1.4%) |
| June 2014 | - | $38.29 M(-15.7%) |
| Mar 2014 | - | $45.40 M(+38.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $32.85 M(+1.8%) | $32.85 M(+3.0%) |
| Sept 2013 | - | $31.91 M(-0.1%) |
| June 2013 | - | $31.93 M(-0.1%) |
| Mar 2013 | - | $31.97 M(-0.9%) |
| Dec 2012 | $32.26 M(+2.0%) | $32.26 M(-6.8%) |
| Sept 2012 | - | $34.63 M(+0.7%) |
| June 2012 | - | $34.39 M(+5.3%) |
| Mar 2012 | - | $32.66 M(+3.3%) |
| Dec 2011 | $31.62 M(+1.9%) | $31.62 M(-6.0%) |
| Sept 2011 | - | $33.64 M(+2.4%) |
| June 2011 | - | $32.86 M(+2.6%) |
| Mar 2011 | - | $32.04 M(+3.3%) |
| Dec 2010 | $31.03 M(-1.6%) | $31.03 M(-3.3%) |
| Sept 2010 | - | $32.10 M(-8.2%) |
| June 2010 | - | $34.98 M(+0.7%) |
| Mar 2010 | - | $34.75 M(+10.2%) |
| Dec 2009 | $31.53 M(+824.5%) | $31.53 M(+275.7%) |
| Sept 2009 | - | $8.39 M(-25.9%) |
| June 2009 | - | $11.33 M(+225.6%) |
| Mar 2009 | - | $3.48 M(+2.0%) |
| Dec 2008 | $3.41 M(-73.3%) | $3.41 M(-14.3%) |
| Sept 2008 | - | $3.98 M(-58.9%) |
| June 2008 | - | $9.68 M(-6.2%) |
| Mar 2008 | - | $10.32 M(-19.3%) |
| Dec 2007 | $12.78 M(+40.3%) | $12.78 M(-16.6%) |
| Sept 2007 | - | $15.31 M(+69.6%) |
| June 2007 | - | $9.03 M(+30.6%) |
| Mar 2007 | - | $6.91 M(-24.1%) |
| Dec 2006 | $9.11 M(+79.8%) | $9.11 M(-9.7%) |
| Sept 2006 | - | $10.09 M(-40.7%) |
| June 2006 | - | $17.03 M(+54.8%) |
| Mar 2006 | - | $11.00 M(+117.1%) |
| Dec 2005 | $5.06 M(+212.0%) | $5.06 M |
| Dec 2004 | $1.62 M(-99.3%) | - |
| Dec 2003 | $249.45 M(+13.5%) | - |
| Dec 2002 | $219.75 M(+18.0%) | - |
| Dec 2001 | $186.31 M(+10.3%) | - |
| Dec 2000 | $168.89 M(+18.9%) | - |
| Dec 1999 | $142.00 M(-2.5%) | - |
| Dec 1998 | $145.60 M(+136.7%) | - |
| Dec 1997 | $61.50 M(+76.2%) | - |
| Dec 1996 | $34.90 M(+436.9%) | - |
| Dec 1995 | $6.50 M(+51.2%) | - |
| Dec 1994 | $4.30 M | - |
FAQ
- What is Vanda Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual current liabilities year-on-year change?
- What is Vanda Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly current liabilities year-on-year change?
What is Vanda Pharmaceuticals annual total current liabilities?
The current annual current liabilities of VNDA is $87.70 M
What is the all time high annual current liabilities for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual total current liabilities is $249.45 M
What is Vanda Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, VNDA annual total current liabilities has changed by -$3.74 M (-4.09%)
What is Vanda Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of VNDA is $89.09 M
What is the all time high quarterly current liabilities for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly total current liabilities is $93.79 M
What is Vanda Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, VNDA quarterly total current liabilities has changed by +$4.25 M (+5.01%)